"Neurotoxin Compositions For Use In Treating Headache" in Patent Application Approval Process (USPTO 20240252603).

A patent application has been filed for a new method of treating headaches, specifically migraines, using neurotoxins. The current FDA-approved treatment, BOTOX, can have side effects such as muscle weakness and involves multiple injections. The new method aims to simplify the injection process and reduce side effects by targeting specific nerve pathways involved in migraines. The patent application outlines various injection sites and combinations that can be used to enhance the treatment's effectiveness. By avoiding certain areas, the occurrence and severity of side effects can be reduced. The inventors claim that their methods can provide more effective and targeted treatment for migraines and headaches. [Extracted from the article]